ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4,8,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,9,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
4,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6,1,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
6,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
9,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
12,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
13,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
14,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
14,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
15,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
15,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
16,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
17,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
17,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
18,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
18,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
19,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
19,3,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
19,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
20,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
20,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
21,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
21,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
21,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
21,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
24,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
24,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
24,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
25,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
26,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
27,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
27,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
27,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
27,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
28,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
29,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
29,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
30,1,Retinal cyst,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
30,2,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
30,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
30,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
31,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
31,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
31,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
33,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
34,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
34,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
35,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
36,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
36,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
37,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
37,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
38,1,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
38,2,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
39,1,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
39,2,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
39,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
40,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
42,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
43,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
44,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
45,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
46,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
47,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
47,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
47,3,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
47,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
47,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
47,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
47,8,Headache,Headaches NEC,Headaches,Nerv,N
47,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
47,10,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
47,11,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
48,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
49,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
50,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
51,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
52,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
53,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
55,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
56,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
57,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
57,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
58,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
59,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
60,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
60,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
61,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
61,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,1,Headache,Headaches NEC,Headaches,Nerv,N
63,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
64,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
65,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
66,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
67,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
67,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
68,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
68,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
68,4,Sarcopenia,Muscle weakness conditions,Muscle disorders,Musc,N
68,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
69,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
70,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
71,2,Soft tissue swelling,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,3,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
72,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
73,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
74,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
75,1,Haematospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
76,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
76,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
76,3,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
76,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
76,5,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
76,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
77,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
78,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
78,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
78,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
79,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
79,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
79,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,6,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
80,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
80,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
80,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
81,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
81,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,6,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
81,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
82,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
82,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
83,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
83,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
83,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
84,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
84,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
84,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
85,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
85,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
85,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
86,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
86,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
86,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,4,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
86,5,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
87,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
87,2,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
88,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
88,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
89,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
93,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
94,1,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
95,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
96,1,Product label confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
96,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
96,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
97,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
97,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
98,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
101,1,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
102,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
102,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
102,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
103,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
104,1,Ocular retrobulbar haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
105,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
106,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
106,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
106,3,Ejection fraction abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
106,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
107,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
108,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
109,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
110,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
111,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,1,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
113,1,Leser-Trelat sign,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
114,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,3,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
114,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
114,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,6,Peripancreatic fluid collection,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
114,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
114,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
114,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
114,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
116,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
116,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
117,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Headache,Headaches NEC,Headaches,Nerv,N
117,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
117,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
117,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
118,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
119,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
119,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
119,3,Headache,Headaches NEC,Headaches,Nerv,N
119,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
121,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
121,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
122,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
122,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
123,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
123,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
123,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
124,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
124,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
125,1,Halo vision,Visual disorders NEC,Vision disorders,Eye,N
125,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
126,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
126,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
126,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
126,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
126,10,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
126,11,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,12,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
126,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
126,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
126,15,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,16,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
126,17,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
126,18,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
126,19,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
126,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,23,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,24,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,25,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
126,26,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
126,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
127,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
128,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
128,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
128,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
128,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
129,1,Bone deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
129,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
129,3,Hip deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
130,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
131,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
132,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
132,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
132,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
132,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
133,1,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
133,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
134,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
134,3,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
